Atara Biotherapeutics (0HIY) Financial Statements
Atara Biotherapeutics Financial Overview
Atara Biotherapeutics's market cap is currently $80.40M. The company's EPS TTM is $-1.18; its P/E ratio is -6.79; Atara Biotherapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 120.77M | $ 128.94M | $ 8.57M | $ 63.57M | $ 20.34M |
| Gross Profit | $ 99.56M | $ 107.93M | $ -313.00K | $ -206.42M | $ -261.66M |
| Operating Income | $ 35.86M | $ -83.44M | $ -276.01M | $ -280.51M | $ -340.46M |
| EBITDA | $ 38.63M | $ -75.75M | $ -266.00M | $ -222.26M | $ -330.75M |
| Net Income | $ 32.69M | $ -85.40M | $ -276.13M | $ -228.30M | $ -340.14M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.48M | $ 42.50M | $ 51.73M | $ 242.82M | $ 371.07M |
| Total Assets | $ 20.23M | $ 109.10M | $ 165.50M | $ 376.42M | $ 468.13M |
| Total Debt | $ 52.80M | $ 43.83M | $ 57.87M | $ 71.70M | $ 28.27M |
| Net Debt | $ 44.32M | $ 18.80M | $ 32.03M | $ -21.24M | $ -77.81M |
| Total Liabilities | $ 58.74M | $ 206.38M | $ 264.74M | $ 249.78M | $ 188.51M |
| Stockholders' Equity | $ -38.50M | $ -97.28M | $ -99.23M | $ 126.64M | $ 279.61M |
| Cash Flow | |||||
| Free Cash Flow | $ -50.94M | $ -68.96M | $ -194.20M | $ -274.62M | $ -231.10M |
| Operating Cash Flow | $ -50.94M | $ -68.72M | $ -192.98M | $ -270.43M | $ -220.52M |
| Investing Cash Flow | $ 18.15M | $ 8.62M | $ 123.87M | $ 202.96M | $ 22.26M |
| Financing Cash Flow | $ 16.10M | $ 59.28M | $ 2.01M | $ 53.08M | $ 103.94M |
Currency in USD